Zepp Health Corporation
ZEPP
$2.53
-$0.13-4.89%
NYSE
| 12/31/2024 | 09/30/2024 | 03/31/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -49.31% | -49.31% | -42.53% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -49.31% | -49.31% | -42.53% |
| Cost of Revenue | -- | -- | -56.89% | -56.88% | -47.38% |
| Gross Profit | -- | -- | -16.31% | -16.29% | -22.34% |
| SG&A Expenses | -- | -- | -29.99% | -30.04% | -31.14% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | -50.23% | -50.24% | -43.29% |
| Operating Income | -- | -- | 59.28% | 59.47% | 50.84% |
| Income Before Tax | -- | -- | 59.28% | 59.47% | 37.10% |
| Income Tax Expenses | -- | -- | 111.58% | 111.60% | 75.38% |
| Earnings from Continuing Operations | -- | -- | 47.80% | 48.02% | 28.40% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -36.36% | -36.17% | -35.53% |
| Net Income | -- | -- | 47.82% | 48.05% | 28.38% |
| EBIT | -- | -- | 59.28% | 59.47% | 50.84% |
| EBITDA | -- | -- | 68.15% | 68.30% | 58.58% |
| EPS Basic | -- | -- | 49.28% | 49.51% | 27.74% |
| Normalized Basic EPS | -- | -- | 69.39% | 69.67% | 50.13% |
| EPS Diluted | -- | -- | 47.05% | 49.50% | 25.58% |
| Normalized Diluted EPS | -- | -- | 69.34% | 69.61% | 50.08% |
| Average Basic Shares Outstanding | -- | -- | 0.71% | 0.71% | -1.20% |
| Average Diluted Shares Outstanding | -- | -- | 2.03% | 2.03% | 0.12% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |